This speculative narrative follows an algorithm designer whose research on basal body temperature and impulsivity draws interest from health-tech investors. As a mandate to prevent accidents becomes a tool for consumer targeting, the protagonist confronts a moral dilemma over ownership, commercialization, and the personal cost of innovation.
